The efficacy and safety of vincristine, irinotecan and anlotinib in Epithelioid Sarcoma

被引：0
|
作者：
Lu Xie
Xin Sun
Jie Xu
Xin Liang
Kuisheng Liu
Kunkun Sun
Rongli Yang
Xiaodong Tang
Wei Guo
机构：
[1] Peking University People’s Hospital,Musculoskeletal Tumor Center
[2] Peking University People’s Hospital,Pathology Department
来源：
BMC Cancer | / 24卷
关键词：
Epithelioid sarcoma; Systemic treatment; Objective response; Toxicity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The efficacy and safety of vincristine, irinotecan and anlotinib in Epithelioid Sarcoma
    Xie, Lu
    Sun, Xin
    Xu, Jie
    Liang, Xin
    Liu, Kuisheng
    Sun, Kunkun
    Yang, Rongli
    Tang, Xiaodong
    Guo, Wei
    BMC CANCER, 2024, 24 (01)
  • [2] Efficacy of the VIT (vincristine, irinotecan and temozolomide) regimen in adults with metastatic Ewing sarcoma
    Dogan, Izzet
    Iribas, Ayca
    Ahmed, Melin Aydan
    Basaran, Mert
    JOURNAL OF CHEMOTHERAPY, 2023, 35 (04) : 343 - 347
  • [3] Efficacy of vincristine, irinotecan, and temozolomide (VIT) combination in adult patients with metastatic Ewing sarcoma.
    Dogan, Izzet
    Iribas, Ayca
    Ekenel, Meltem
    Basaran, Mert
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] The efficacy and safety of anlotinib combined with chemotherapy in treatment of advanced soft tissue sarcoma
    Ni, Ying
    Dong, Yabing
    Jiang, Aijun
    Zhang, Qun
    Wang, Zhantong
    Liang, Hui
    Zhang, Wei
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [5] The Efficacy and Safety of Irinotecan Plus Temozolomide and Vincristine in Neuroblastoma with Brain Recurrence: A Retrospective Study
    Wang, J.
    Zhen, Z.
    Zhu, S.
    Lian, Z.
    Lu, S.
    Sun, F.
    Huang, J.
    Zhang, Y.
    Sun, X.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S213 - S214
  • [6] Safety and Efficacy of Chemotherapy Combined with Anlotinib Plus Anlotinib Maintenance in Chinese Patients with Advanced/Metastatic Soft Tissue Sarcoma
    Wang, Hai-ying
    Chu, Jun-feng
    Zhang, Peng
    Wang, Jia-qiang
    Yan, Zheng
    Yao, Shu-na
    Yao, Zhi-hua
    Liu, Yan-yan
    ONCOTARGETS AND THERAPY, 2020, 13 : 1561 - 1568
  • [7] Long-Term Efficacy and Safety of Anlotinib as a Monotherapy and Combined Therapy for Advanced Sarcoma
    Yao, Weitao
    Du, Xinhui
    Wang, Jiaqiang
    Wang, Xin
    Zhang, Peng
    Niu, Xiaohui
    ONCOTARGETS AND THERAPY, 2022, 15 : 669 - 679
  • [8] Vincristine, irinotecan, and temozolomide in patients with relapsed and refractory Ewing sarcoma
    Raciborska, Anna
    Bilska, Katarzyna
    Drabko, Katarzyna
    Chaber, Radoslaw
    Pogorzala, Monika
    Wyrobek, Elzbieta
    Polczynska, Katarzyna
    Rogowska, Elzbieta
    Rodriguez-Galindo, Carlos
    Wozniak, Wojciech
    PEDIATRIC BLOOD & CANCER, 2013, 60 (10) : 1621 - 1625
  • [9] Anlotinib, Vincristine, and Irinotecan for Advanced Ewing Sarcoma After Failure of Standard Multimodal Therapy: A Two-Cohort, Phase Ib/II Trial
    Xu, Jie
    Xie, Lu
    Sun, Xin
    Liu, Kuisheng
    Tang, Xiaodong
    Yan, Taiqiang
    Yang, Rongli
    Guo, Wei
    Gu, Jin
    ONCOLOGIST, 2021, 26 (07): : E1256 - E1262
  • [10] Epithelioid sarcoma: A retrospective study of efficacy and safety of first-line treatment
    Zhang, C.
    Li, W.
    Guo, X.
    You, Y.
    Wang, Z.
    Zhou, Y.
    ANNALS OF ONCOLOGY, 2024, 35
12345